Laurus Labs invests in ImmunoACT to acquire additional stake

Post the completion of the deal, Laurus Labs’ stake in ImmunoACT will increase to 33.86% on fully diluted basis.

Related Keywords

India , United States , Mumbai , Maharashtra , American , Satyanarayana Chava , Rahul Purwar , Laurus Lab , Immunoadoptive Cell Therapy Private , American Society Of Hematology , Laurus Labs , Immunoadoptive Cell Therapy Private Limited , Navi Mumbai , Tata Memorial , American Society , Gene Therapy , Chief Executive , Indian Patients , Lauruslab , Investment , Immunoact , Stakes , Business ,